In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 35 for your search:
Cancer Type/Condition:  Prostate cancer
Treatment/Intervention:  complementary or alternative medicine procedure
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III
Type: Natural history/Epidemiology
Status: Active
Age: 55 and over (50 and over for African Americans)
Sponsor: NCI, Other
Protocol IDs: CDR0000617778, S0000B, U10CA037429, R01EY014418, SWOG-S0000B, NCT00784225

2.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: I 128308, NCI-2009-01530, P30CA016056, RPCI-I-128308, NCT00887432

3.

Phase: Phase III
Type: Health services research, Supportive care
Status: Active
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: 1R01CA127493-01A2, NCT01365182

4.

Phase: Phase III
Type: Educational/Counseling/Training, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UHN REB 09-0855-C, CIHR, NCT01506492

5.

Phase: Phase III
Type: Treatment
Status: Active
Age: 21 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MMC12192-12CTIL, NCT01681823

6.

Phase: Phase II, Phase I
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NYM # 325, NCT00421902

7.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: I 68905, RPCI-I-68905, NCT00536991

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: J1161, NCT01317199

9.

Phase: Phase II, Phase I
Type: Supportive care
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: Application ID 213, NCT01585246

10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SHEBA-06-4232-RW-CTIL, NCT00411853

11.

Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Germanium, NCT00651417

12.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-0580-B, NCT00744549

13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-0604-CE, NCT00844792

14.

Phase: Phase II
Type: Treatment
Status: Active
Age: 30 to 80
Sponsor: Other
Protocol IDs: MCC-15835, IRB 107980, 1P20MD003375-01, NCT01036321

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-008692-33, NCT01080352

16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 50 to 69
Sponsor: Other
Protocol IDs: UB-ProDiet, UB-ProDiet CRUK/07/057, CRUK-07/057, ISRCTN-95931417, EU-21031, NCT01105338

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NCI 09U2, NCI-2010-00941, STU00019487, P50CA090386, NCT01126879

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00451, UWI09-14-01, CDR0000698228, CO-10805, N01CN35153, P30CA014520, NCT01325311

19.

Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 65 and over
Sponsor: Other
Protocol IDs: 00016781, NCT01607879

20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 19 to 90
Sponsor: Other
Protocol IDs: CLIN-007-12S, Pro00019745, NCT01759771

21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 45 to 85
Sponsor: NCI, Other
Protocol IDs: CASE6812, NCI-2013-01372, P30CA043703, NCT01928485

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: Over 19
Sponsor: Other
Protocol IDs: 264-2013, NCT02037464

23.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 80
Sponsor: Other
Protocol IDs: UTSWYL1, NCT02064673

24.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 60 and over
Sponsor: Other
Protocol IDs: 1R21CA175793-01A1, NCT02064946

25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 21 and over
Sponsor: NCI
Protocol IDs: NCI-2014-00695, CO11378, UWI2013-00-01, P30CA014520, N01CN00033, N01CN35153, NCT02095145
1   
New Search